• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    In his State of the Union address Tuesday night, President Trump did not say he had any intention of eliminating any other part of Obamacare, after the law's individual mandate was repealed last year. (AP Photo/Pablo Martinez Monsivais)
    Economy

    Republican lawmakers take Trump’s Obamacare repeal snub in stride

    Robert King -
    January 31, 2018 5:01 am
    0
    Healthcare

    Trump promises drug prices ‘will come down’

    Robert King -
    January 31, 2018 2:43 am
    0
    Pictured above is the Pfizer Inc. Research and Development Center in Cambridge, Mass. The drugmaker is investing $5 billion, some in strengthening U.S. manufacturing operations, after a tax break passed by Republicans late last year. (Scott Eisen/Bloomberg)
    Business

    With $5 billion investment, Pfizer joins corporate icons spending tax-bill savings

    James Langford -
    January 30, 2018 8:32 pm
    0
    The president emphasized that Alex Azar would tackle opioids and prescription drug prices. (AP Photo/Andrew Harnik)
    Healthcare

    Trump: Health chief to bring drug prices ‘rocketing down’

    Kimberly Leonard -
    January 29, 2018 5:45 pm
    0
    Accepted current medical practice both among clinical professionals and the insurance industry suggests that people really should be open to considering e-cigarettes as a form of
    Beltway Confidential

    E-cigarettes are what the doctor ordered

    Eli Lehrer -
    January 29, 2018 4:44 pm
    0
    Trump’s first year sees record number of generic drug approvals
    Healthcare

    Trump’s first year sees record number of generic drug approvals

    Kimberly Leonard -
    January 26, 2018 2:27 pm
    0
    Alex Azar is a former health official at HHS, where he served as deputy secretary under former President George W. Bush. He also is a former top executive for pharmaceutical giant Eli Lilly. (Graeme Jennings/Washington Examiner)
    Healthcare

    Senate confirms Alex Azar to be Trump’s health secretary

    Kimberly Leonard -
    January 24, 2018 7:42 pm
    0
    Congress created the 340B drug pricing program in 1992 to offset some of the costs hospitals incur when they treat uninsured and underinsured patients.
    Healthcare

    Hospitals should accept the cuts to 340B drug payments

    Tara O'Neill Hayes -
    January 22, 2018 5:01 am
    0
    While many in D.C. may be indifferent to the state of today's politics, many people are sick and tired of it. They want to see civility restored, to see elected officials put their differences aside, and to see results. (AP Photo/Charles Dharapak)
    Beltway Confidential

    Rep. Gus Bilirakis: Restore civility & embrace bipartisanship

    Rep. Gus Bilirakis -
    January 19, 2018 6:54 pm
    0
    Pharmaceutical companies vying for public sector spending will compete for positive attention and attempt to shape public opinion. (AP Photo/Carla K. Johnson)
    Healthcare

    Don’t let opioid treatment turn into a partisan issue

    Matt Mossburg -
    January 18, 2018 5:01 am
    0
    1...102103104...159Page 103 of 159
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.